Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

107 ARTÍCULOS , VIENDO DEL 76 AL 90

Pharmacokinetics, safety and tolerability of rotigotine transdermal patch in healthy Japanese and Caucasian subjects

Cawello W, Kim SR, Braun M, Elshoff JP, Ikeda J, Funaki T.

Clin Drug Investig. 2014 Feb;34(2):95-105. doi: 10.1007/s40261-013-0150-5.

Restless legs syndrome in Parkinson's disease

Rijsman RM, Schoolderman LF, Rundervoort RS, Louter M.

Parkinsonism Relat Disord. 2014 Jan;20 Suppl 1:S5-9. doi: 10.1016/S1353-8020(13)70004-X.

Treatment of the sleep disorders associated with Parkinson's disease

Trotti LM, Bliwise DL.

Neurotherapeutics. 2014 Jan;11(1):68-77. doi: 10.1007/s13311-013-0236-z.

Implications of nocturnal symptoms towards the early diagnosis of Parkinson's disease

Slow EJ, Postuma RB, Lang AE.

J Neural Transm (Vienna). 2014 Aug;121 Suppl 1:S49-57. doi: 10.1007/s00702-014-1168-4. Epub 2014 Feb 6.

Effects of gabapentin enacarbil on restless legs syndrome and leg pain in dementia with Lewy bodies

Fujishiro H.

Psychogeriatrics. 2014 Jun;14(2):132-4. doi: 10.1111/psyg.12043. Epub 2014 Feb 16.

Rating scales and questionnaires for assessment of sleep disorders in Parkinson's disease: what they inform about?

Zea-Sevilla MA, Martínez-Martín P.

J Neural Transm (Vienna). 2014 Aug;121 Suppl 1:S33-40. doi: 10.1007/s00702-014-1217-z. Epub 2014 Apr 23.

Microsubthalamotomy improves sleep in patients affected by advanced Parkinson's disease

Merlino G, Lettieri C, Mondani M, Belgrado E, Devigili G, Mucchiut M, Rinaldo S, Craighero C, D'Auria S, Skrap M, Eleopra R.

Sleep Med. 2014 Jun;15(6):637-41. doi: 10.1016/j.sleep.2013.12.016. Epub 2014 Feb 28.

Sleep disorders in Parkinson's disease

Schrempf W, Brandt MD, Storch A, Reichmann H.

J Parkinsons Dis. 2014;4(2):211-21. doi: 10.3233/JPD-130301.

Diagnosis, comorbidities, and management of restless legs syndrome

Becker PM, Novak M.

Curr Med Res Opin. 2014 Aug;30(8):1441-60. doi: 10.1185/03007995.2014.918029. Epub 2014 May 9.

Rotigotine transdermal system: developing continuous dopaminergic delivery to treat Parkinson's disease and restless legs syndrome

Benitez A, Edens H, Fishman J, Moran K, Asgharnejad M.

Ann N Y Acad Sci. 2014 Nov;1329:45-66. doi: 10.1111/nyas.12508. Epub 2014 Aug 21.

Rotigotine: the first new chemical entity for transdermal drug delivery

McAfee DA, Hadgraft J, Lane ME.

Eur J Pharm Biopharm. 2014 Nov;88(3):586-93. doi: 10.1016/j.ejpb.2014.08.007. Epub 2014 Aug 27.

Review of Severity Rating Scales for Restless Legs Syndrome: Critique and Recommendations

Walters AS, Frauscher B, Allen R, Benes H, Chaudhuri KR, Garcia-Borreguero D, Lee HB, Picchietti DL, Trenkwalder C, Martinez-Martin P, Schrag A, Stebbins G.

Mov Disord Clin Pract. 2014 Sep 30;1(4):317-324. doi: 10.1002/mdc3.12088. eCollection 2014 Dec.

Genome-wide association studies in neurology

Tan MS, Jiang T, Tan L, Yu JT.

Ann Transl Med. 2014 Dec;2(12):124. doi: 10.3978/j.issn.2305-5839.2014.11.12.

[Sleep disturbance in Parkinson's disease]

Nomura T, Inoue Y, Nakashima K.

Rinsho Shinkeigaku. 2014;54(12):987-90. doi: 10.5692/clinicalneurol.54.987.

Sensory aspects of movement disorders

Patel N, Jankovic J, Hallett M.

Lancet Neurol. 2014 Jan;13(1):100-12. doi: 10.1016/S1474-4422(13)70213-8.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias